Psycho- und Pharmakotherapie bei schädlichem Tabakgebrauch und -abhängigkeit

详细信息    查看全文

• 作者：Prof. Dr. A. Batra ; K. U. Petersen ; E. Hoch ; K. Mann ; C. Kröger…
• 关键词：Treatment practice guidelines ; Substance ; related disorders ; Tobacco use disorders ; Psychotherapy ; Pharmacotherapy
• 刊名：Der Nervenarzt
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：87
• 期：1
• 页码：35-45
• 全文大小：349 KB
• 参考文献：1.Agboola S, McNeill A, Coleman T, Leonardi Bee J (2010) A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction 105(8):1362–1380PubMed CrossRef
  2.Audrain-McGovern J, Stevens S, Murray PJ, Kinsman S, Zuckoff A, Pletcher J, Moss D, Baumritter A, Klakhuis-Beam S, Carlson E, Rodriguez D, Wileyto EP (2011) The efficacy of motivational interviewing versus brief advice for adolescent smoking behavior change. Pediatrics 128(1):e101–e111PubMed CrossRef
  3.Barnes J, Dong CY, McRobbie H, Walker N, Mehta M, Stead LF (2010) Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001008.pub2
  4.Batra A, Hoch E, Mann K, Petersen KU (2015) S3-Leitlinie. Screening, Diagnose und Behandlung des schädlichen und abhängigen Tabakkonsums. Springer, HeidelbergCrossRef
  5.Batra A (2011) Therapie der Tabakabhängigkeit. Dtsch Aerztebl Int 108(33):555–564
  6.Cahill K, Stead LF, Lancaster T (2013) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD006103.pub6
  7.Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A (2010) Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. Health Technol Assess 14(49):1–152PubMed CrossRef
  8.Etter JF, Stapleton JA (2006) Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 15(4):280–285PubMed PubMedCentral CrossRef
  9.Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz N, Curry SJ (2008) Treating tobacco use and dependence: 2008 update US Public Health Service Clinical Practice Guideline executive summary. Respir Care 53(9):1217–1222
  10.Gourlay SG, Stead LF, Benowitz N (2004) Clonidine for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000058.pub2PubMed
  11.Hajek P, Stead LF, West R, Jarvis M, Lancaster T (2009) Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD003999.pub3
  12.Hall SM, Humfleet GL, Munoz RF, Reus VI, Prochaska JJ, Robbins JA (2011) Using extended cognitive behavioral treatment and medication to treat dependent smokers. Am J Public Health 101(12):2349–2356PubMed PubMedCentral CrossRef
  13.Hettema JE, Hendricks PS (2010) Motivational interviewing for smoking cessation: a meta-analytic review. J Consult Clin Psychol 78(6):868–884PubMed CrossRef
  14.Hoch E, Petersen K, Batra A, Mann K (2015) Methodik der S3-Leitlinien für alkohol- und tabakbezogeneStörungen. Nervenarzt : (im Druck)
  15.Hughes JR (2007) Depression during tobacco abstinence. Nicotine Tob Res 9(4):443–446
  16.Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T (2014) Antidepressants for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000031.pub4
  17.Hughes JR, Stead LF, Lancaster T (2005) Nortriptyline for smoking cessation: a review. Nicotine Tob Res 7(4):491–499PubMed CrossRef
  18.Javitz HS, Swan GE, Lerman C (2011) The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. Addiction 106(10):1835–1845PubMed CrossRef
  19.Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340(9):685–691
  20.Killen JD, Fortmann SP, Murphy GM, Hayward C, Arredondo C, Cromp D, Celio M, Abe L, Wang Y, Schatzberg AF (2006) Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol 74(2):286–294PubMed CrossRef
  21.Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M (2008) Extended cognitive behavior therapy for cigarette smoking cessation. Addiction 103(8):1381–1390PubMed PubMedCentral CrossRef
  22.Laniado-Laborín R (2010) Smoking cessation intervention: an evidence-based approach. Postgrad Med 122(2):74–82PubMed CrossRef
  23.Levine MD, Perkins KA, Kalarchian MA, Cheng Y, Houck PR, Slane JD, Marcus MD (2010) Bupropion and cognitive behavioral therapy for weight-concerned women smokers. Arch Intern Med 170(6):543–550. doi:10.1001/archinternmed.2010.33
  24.Loh WY, Piper ME, Schlam TR, Fiore MC, Smith SS, Jorenby DE, Cook JW, Bolt DM, Baker TB (2011) Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res 14(2):131–141PubMed PubMedCentral CrossRef
  25.McRobbie H, Thornley S, Bullen C, Lin RB, Senior H, Laugesen M, Whittaker R, Hajek P (2010) A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction. Addiction 105(7):1290–1298. doi:10.1111/j.1360-0443.2010.02950.xPubMed CrossRef
  26.Mottillo S, Filion KB, Belisle P, Joseph L, Gervais A, O’Loughlin J, Paradis G, Pihl R, Pilote L, Rinfret S, Tremblay M, Eisenberg MJ (2009) Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J 30(6):718–730PubMed CrossRef
  27.Mühlig S, Andreas S, Batra A, Petersen KU, Hoch E, Rüther E (2015) Psychiatrische Komorbiditäten bei tabakbedingten Störungen. Nervenarzt. doi:10.1007/s00115-015-0020-x. (im Druck)
  28.Niaura R, Hays JT, Jorenby DE, Leone FT, Pappas JE, Reeves KR, Williams KE, Billing CB (2008) The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. Curr Med Res Opin 24(7):1931–1941PubMed CrossRef
  29.Piper ME, Federman EB, McCarthy DE, Bolt DM, Smith SS, Fiore MC, Baker TB (2007) Efficacy of bupropion alone and in combination with nicotine gum. Nicotine Tob Res 9(9):947–954PubMed PubMedCentral CrossRef
  30.Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB (2009) A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 66(11):1253–1262. doi:10.1001/archgenpsychiatry.2009.142
  31.Ramos M, Ripoll J, Estrades T, Socias I, Fe A, Duro R, Gonzalez J, Servera M (2010) Effectiveness of intensive group and individual interventions for smoking cessation in primary health care settings: a randomized trial. BMC Public Health 10(1):89PubMed PubMedCentral CrossRef
  32.Rovina N, Nikoloutsou I, Katsani G, Dima E, Fransis K, Roussos C, Gratziou C (2009) Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice. Ther Adv Respir Dis 3(6):279–287. doi:10.1177/1753465809350653
  33.Schmelzle J, Rosser WW, Birthwhistle R (2008) Update on pharmacologic and nonpharmacologic therapies for smoking cessation. Can Fam Physician 54(7):994–999PubMed PubMedCentral
  34.Spring B, Howe D, Berendsen M, McFadden HG, Hitchcock K, Rademaker AW, Hitsman B (2009) Behavioral intervention to promote smoking cessation and prevent weight gain: a systematic review and meta-analysis. Addiction 104(9):1472–1486PubMed PubMedCentral CrossRef
  35.Stapleton JA, Sutherland G (2011) Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial. Addiction 106(4):824–832. doi:10.1111/j.1360-0443.2010.03274.xPubMed CrossRef
  36.Stapleton J, West R, Hajek P, Wheeler J, Vangeli E, Abdi Z, O’Gara C, McRobbie H, Humphrey K, Ali R, Strang J, Sutherland G (2013) Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice. Addiction 108(12):2193–2201. doi:10.1111/add.12304
  37.Statistisches Bundesamt (2014) Mikrozensus-Fragen zur Gesundheit - Rauchgewohnheiten der Bevölkerung 2014. Statistisches Bundesamt, Wiesbaden
  38.Stead LF, Lancaster T (2012) Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008286.pub2PubMedCentral
  39.Stead LF, Lancaster T (2005) Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001007.pub2
  40.Stead LF, Perera R, Bullen C,Mant D, Hartmann-Boyce J, Cahill K, Lancaster T (2012) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 11:CD000146. doi:10.1002/14651858.CD000146.pub4
  41.Tahiri M, Mottillo S, Joseph L, Pilote L, Eisenberg MJ (2012) Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med 125(6):576–584PubMed CrossRef
  42.Whittaker R, Borland R, Bullen C, Lin RB, McRobbie H, Rodgers A (2009) Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. doi:10.1002/14651858.CD006611.pub2PubMed
  43.Wittchen HU, Hoch E, Klotsche J, Muehlig S (2011) Smoking cessation in primary care – a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention. Int J Methods Psychiatr Res 20(1):28–39PubMed CrossRef
  
• 作者单位：Prof. Dr. A. Batra (1)
  K. U. Petersen (1)
  E. Hoch (2) (9)
  K. Mann (2)
  C. Kröger (3)
  C. Schweizer (4)
  A. Jähne (5)
  T. Rüther (6)
  N. Thürauf (7)
  S. Mühlig (8)
  
  1. Sektion Suchtforschung und Suchttherapie, Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Tübingen, Calwer Str. 14, 72076, Tübingen, Deutschland
  2. Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Mannheim, Deutschland
  9. Abt. Psychotherapie & Psychosomatik, Klinik und Poliklinik für Psychiatrie und Psychotherapie der LMU München, München, Deutschland
  3. Institut für Therapieforschung (IfT), München, Deutschland
  4. Milton-Erickson-Gesellschaft, Tübingen, Deutschland
  5. Rhein-Jura-Klinik, Bad Säckingen, Deutschland
  6. Klinik für Psychiatrie und Psychotherapie, Klinikum der Universität München, München, Deutschland
  7. Psychiatrische und Psychotherapeutische Klinik, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland
  8. Institut für Psychologie, Klinische Psychologie und Psychotherapie, Technische Universität Chemnitz, Chemnitz, Deutschland
  
• 刊物主题：Medicine/Public Health, general; Neurology; Neurosurgery; Psychiatry; Psychotherapy;
• 出版者：Springer Berlin Heidelberg
• ISSN：1433-0407

文摘

Tobacco consumption is one of the major preventable health risk factors. In Germany approximately 110,000 people prematurely die from tobacco-related diseases and approximately 50 % of regular smokers are considered to be tobacco dependent. Nevertheless, motivation to quit smoking is low and the long-term abstinence rates after attempts to stop smoking without professional support are far below 10 %. As part of the S3 treatment guidelines 78 recommendations for motivation and early interventions for smokers unwilling to quit as well as psychotherapeutic and pharmacological support for smokers willing to quit were formulated after an systematic search of the current literature. More than 50 professional associations adopted the recommendations and background information in a complex certification process. In this article the scientific evidence base regarding the psychotherapeutic and pharmacological treatment options as well as recommendations and further information about indications and treatment implementation are presented. By following these guidelines for treatment of heavy smokers who are willing to quit combined with individual and group therapies on the basis of behavioral treatment strategies and pharmacological support, long-term success rates of almost 30 % can be achieved.